Zobrazeno 1 - 10
of 29
pro vyhledávání: '"E Tejedor-Tejada"'
Autor:
M Rodriguez Goicoechea, B Morales Rivero, E Tejedor Tejada, N Garcia Gomez, MJ Barbero Hernández, F Horno Ureña
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02987b85c5d79c47219e1fc401edd58d
https://doi.org/10.1136/ejhpharm-2023-eahp.211
https://doi.org/10.1136/ejhpharm-2023-eahp.211
Publikováno v:
Section 1: Introductory statements and governance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99de3db6879c0eaa1ef9ae56d72527c6
https://doi.org/10.1136/ejhpharm-2023-eahp.11
https://doi.org/10.1136/ejhpharm-2023-eahp.11
Autor:
M Rodriguez Goicoechea, E Tejedor Tejada, S Cano Dominguez, A Moreno Lopez, N Garcia Gomez, MJ Barbero Hernández, F Horno Ureña
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac21f776169a077c91a5a3f06a298b0e
https://doi.org/10.1136/ejhpharm-2023-eahp.166
https://doi.org/10.1136/ejhpharm-2023-eahp.166
Autor:
E Tejedor Tejada, M Rodriguez Goicoechea, A Moreno Lopez, N Garcia Gomez, MJ Barbero Hernandez, F Horno Ureña
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdbcf442ed35c1ad6f59bc2234759d14
https://doi.org/10.1136/ejhpharm-2023-eahp.140
https://doi.org/10.1136/ejhpharm-2023-eahp.140
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60e71e34a082573d57169386a1fdc897
https://doi.org/10.1136/ejhpharm-2022-eahp.272
https://doi.org/10.1136/ejhpharm-2022-eahp.272
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21c3fef627394efd8872c7495d9c8246
https://doi.org/10.1136/ejhpharm-2022-eahp.113
https://doi.org/10.1136/ejhpharm-2022-eahp.113
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d966d8b2316c92ac190761e527512ad
https://doi.org/10.1136/ejhpharm-2022-eahp.295
https://doi.org/10.1136/ejhpharm-2022-eahp.295
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::972f474f961bd95a769201fa0eeac5c8
https://doi.org/10.1136/ejhpharm-2022-eahp.60
https://doi.org/10.1136/ejhpharm-2022-eahp.60
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Inflammatory/autoimmune ophthalmic syndromes (IAOS) are often treated with corticosteroids in severe cases. However, in some cases, corticosteroids can be contraindicated, poorly tolerated or ineffective. This situation is c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51c26ccff8115cf86c938d1691d87679
https://doi.org/10.1136/ejhpharm-2021-eahpconf.150
https://doi.org/10.1136/ejhpharm-2021-eahpconf.150
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Squamous cell carcinoma (SCC) is the second most common skin cancer. This type of cancer is most often found in areas which have been exposed to sunlight, such as the neck, head and arms, although it can occur anywhere on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a5711a210f386e1073c6244607e5fe
https://doi.org/10.1136/ejhpharm-2021-eahpconf.132
https://doi.org/10.1136/ejhpharm-2021-eahpconf.132